We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.8B
AUM Growth
-$877M
Cap. Flow
-$1.07B
Cap. Flow %
-18.41%
Top 10 Hldgs %
67.63%
Holding
285
New
60
Increased
42
Reduced
77
Closed
80

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$31.9M
2
GEHC icon
GE HealthCare
GEHC
+$31.5M
3
IBRX icon
ImmunityBio
IBRX
+$20.9M
4
GTLB icon
GitLab
GTLB
+$14.8M
5
VSTM icon
Verastem
VSTM
+$13.4M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$52.3M
2
SPB icon
Spectrum Brands
SPB
+$49.4M
3
SMPL icon
Simply Good Foods
SMPL
+$46.6M
4
SAM icon
Boston Beer
SAM
+$42M
5
DPZ icon
Domino's
DPZ
+$41.4M

Sector Composition

Rank Sector Weight
1 Healthcare 31.42%
2 Consumer Discretionary 5.85%
3 Technology 4.99%
4 Consumer Staples 1.48%
5 Communication Services 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCTXW
201
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$1.88K ﹤0.01%
25,000
– –
KTTAW icon
202
Pasithea Therapeutics Warrants
KTTAW
$25.5K
$1.08K ﹤0.01%
50,000
– –
SBEV.WS
203
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$486 ﹤0.01%
+22,600
New +$1.34K
TNONW icon
204
Tenon Medical Inc Warrant
TNONW
$409 ﹤0.01%
22,250
– –
NLSPW
205
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$250 ﹤0.01%
12,500
– –
APCXW
206
DELISTED
AppTech Payments Corp Warrant
APCXW
– –
-715,000
Closed -$127K
ASMB icon
207
Assembly Biosciences
ASMB
$503M
– –
-23,858
Closed -$228K
AXDX
208
DELISTED
Accelerate Diagnostics
AXDX
– –
-1,879,227
Closed -$1.32M
AYTU icon
209
AYTU BioPharma
AYTU
$24.1M
– –
-57,597
Closed -$69.1K
BCLI
210
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
– –
-690,666
Closed -$870K
BILL icon
211
BILL Holdings
BILL
$4.7B
– –
-156,447
Closed -$7.18M
BIO icon
212
Bio-Rad Laboratories Class A
BIO
$8.96B
– –
-3,827
Closed -$932K
BKYI
213
BIO-key International
BKYI
$4.08M
– –
-44,046
Closed -$348K
CBUS icon
214
Cibus
CBUS
$144M
– –
-1,948,000
Closed -$3.64M
CELZ icon
215
Creative Medical Technology
CELZ
$4.24M
– –
-148,000
Closed -$321K
COSM icon
216
Cosmos Holdings
COSM
$14.6M
– –
-1,917,710
Closed -$836K
CPNG icon
217
Coupang
CPNG
$29.5B
– –
-264,375
Closed -$5.8M
CVNA icon
218
Carvana
CVNA
$72.7B
– –
-25,275
Closed -$1.06M
BGMS
219
Bio Green Med Solution Inc
BGMS
$4.86M
– –
-5,290
Closed -$354K
DPZ icon
220
Domino's
DPZ
$12.1B
– –
-90,068
Closed -$41.4M
EL icon
221
Estee Lauder
EL
$30.6B
– –
-299,157
Closed -$19.7M
CHRN
222
ChronoScale Holdings
CHRN
$3.47B
– –
-136,159
Closed -$823K
ELAN icon
223
Elanco Animal Health
ELAN
$12.8B
– –
-13,105
Closed -$138K
EVGN icon
224
Evogene
EVGN
$6.49M
– –
-316,024
Closed -$395K
EW icon
225
Edwards Lifesciences
EW
$51.1B
– –
-62,995
Closed -$4.57M
7 8
9
10 11

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Armistice Capital held 285 positions worth $5.8B, down 13% from $6.67B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Armistice Capital withdrew a net $1.07B in Q2 2025, closing 80 positions and reducing 77 holdings. Its most notable exit was Spectrum Brands, an estimated $49.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Armistice Capital opened a new position in ImmunityBio worth $20.5M.

  • Armistice Capital's largest Q2 2025 buy was ImmunityBio: 7,764,000 shares worth $20.5M.
  • Armistice Capital added most to McDonald's in Q2 2025, an estimated $31.9M increase.
  • Armistice Capital's biggest Q2 2025 reduction was Exact Sciences, cutting an estimated $52.3M.
  • Armistice Capital fully exited Spectrum Brands in Q2 2025, selling an estimated $49.4M.
  • Armistice Capital's ten largest holdings make up 68% of its $5.8B portfolio in Q2 2025.
  • Armistice Capital opened 60 new positions and closed 80 in Q2 2025.
  • Armistice Capital's portfolio value fell 13% quarter-over-quarter to $5.8B.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.